Abstract 241: Patient-derived organoids as a reliable screening platform for assessing ADC efficacy and specificity

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Abstract 5702: An image-based approach to visualize ADC internalization and cytotoxicity in patient-derived organoids2026
2. 2Abstract 4397: Leveraging patient-derived organoids to investigate bystander effects of antibody-drug conjugates in solid tumor backgrounds2026
3. 3Abstract PS1-09-29: A Rapid Digital Patient-Derived Organoid Guiding Therapy After Antibody Drug Conjugates (ADC)s In Patients with Metastatic Breast Cancer[YY1] [YY1]The size limit (including title and body) is 3,400 characters; this does not include spaces2026
4. 4Abstract 4448: 3D-tumor organoid, over 2D-cell, is more predictive of <i>in vivo</i> anti-cancer pharmacology in assessing ADC candidates2026
5. 5Abstract 6404: A robust organoid-based platform for high-throughput screening and drug discovery2026